| Rapport Therapeutics, Inc. |
10%+ Owner |
Common Stock |
7,135,233 |
$71,209,625 |
$9.98 |
10 Jun 2024 |
Direct |
| Septerna, Inc. |
10%+ Owner |
Common Stock |
6,215,591 |
$36,361,207 |
$5.85 |
28 Oct 2024 |
Direct |
| CARGO Therapeutics, Inc. |
10%+ Owner |
Common Stock |
1,807,119 |
$27,106,785 |
$15.00 |
14 Nov 2023 |
Indirect |
| CARGO Therapeutics, Inc. |
10%+ Owner |
Common Stock |
1,737,216 |
$26,058,240 |
$15.00 |
14 Nov 2023 |
Direct |
| Septerna, Inc. |
10%+ Owner |
Common Stock |
3,152,456 |
$18,441,868 |
$5.85 |
28 Oct 2024 |
Indirect |
| Rapport Therapeutics, Inc. |
10%+ Owner |
Common Stock |
969,218 |
$9,672,796 |
$9.98 |
10 Jun 2024 |
By Third Rock Ventures VI, L.P. |
| CARGO Therapeutics, Inc. |
10%+ Owner |
Series A-1 Preferred Stock |
0 |
|
|
14 Nov 2023 |
Direct |
| CARGO Therapeutics, Inc. |
10%+ Owner |
Series A-1 Preferred Stock |
0 |
|
|
14 Nov 2023 |
Indirect |
| Rapport Therapeutics, Inc. |
10%+ Owner |
Series A Preferred Stock |
0 |
|
|
10 Jun 2024 |
By Third Rock Ventures VI, L.P. |
| Rapport Therapeutics, Inc. |
10%+ Owner |
Series A Preferred Stock |
0 |
|
|
10 Jun 2024 |
Direct |
| Rapport Therapeutics, Inc. |
10%+ Owner |
Series B Preferred Stock |
0 |
|
|
10 Jun 2024 |
By Third Rock Ventures VI, L.P. |
| Septerna, Inc. |
10%+ Owner |
Series A Preferred Stock |
0 |
|
|
28 Oct 2024 |
Direct |
| Septerna, Inc. |
10%+ Owner |
Series B Preferred Stock |
0 |
|
|
28 Oct 2024 |
Indirect |